Damien Fink

Head, Analytical Development
Century Therapeutics

Damien currently leads the Analytical Development group at Century Therapeutics. He’s a graduate (and avid fan) of Pennsylvania State University and Villanova University. His experience in Analytical Development stems from his tenure at Merck Manufacturing Division (4+ years) and Janssen R&D (16+ years) where he worked extensively on assay development and validation efforts in both the GMP and GLP space relating to products such as Recombivax HB, Vaqta, Gardasil, golimumab, amivantamab, teclistamab, talquetamab, and ciltacabtagene autoleucel among many others. In his current role, he leads the development of release and characterization assays ensuring the quality of iPSC-derived allogenic cell therapies and serves as CMC lead on current collaboration projects. He lives in Collegeville, Pennsylvania with his wife and two daughters.